World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
47
Citations
15026
World Ranking
18554
National Ranking
7579

Russell P. Rother publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Russell P. Rother sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 119 publications — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Russell P. Rother D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Russell P. Rother sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 47 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Russell P. Rother is affiliated with Tetherex Pharmaceuticals in the United States and has conducted research primarily in the field of Medicine. Their work encompasses several subfields, including Pulmonary and Respiratory Medicine, Genetics, Pediatrics, Perinatology and Child Health, Hematology, and Physiology.

The scientist has contributed to research published in notable venues such as UNC Libraries and the European Respiratory Journal. Their recent papers include "Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease" published in 2020 by UNC Libraries, and "Reduction in sputum inflammatory cells after a single dose of cepeprubart in COPD patients" published in 2025 by the European Respiratory Journal.

Russell P. Rother's research topics focus on various health and biomedical areas including:

  • Hemoglobinopathies and Related Disorders
  • Pharmacological Effects and Toxicity Studies
  • Iron Metabolism and Disorders
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Asthma and respiratory diseases
  • Respiratory and Cough-Related Research

The scientist has collaborated with several frequent co-authors, including:

  • Kenneth I. Ataga
  • Abdullah Kutlar
  • Julie Kanter
  • Darla Liles
  • Rodolfo Delfini Cançado

Best Publications

  • The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease.

    Russell P. Rother;Leonard Bell;Peter Hillmen;Mark T. Gladwin

  • The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.

    Peter Hillmen;Neal S. Young;Jörg Schubert;Robert A. Brodsky

  • Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

    Russell P Rother;Scott A Rollins;Christopher F Mojcik;Robert A Brodsky

  • Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.

    Peter Hillmen;Claire Hall;Judith C W Marsh;Modupe Elebute

  • Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease.

    Kenneth I. Ataga;Abdullah Kutlar;Julie Kanter;Darla Liles

  • Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria.

    Robert A. Brodsky;Neal S. Young;Elisabetta Antonioli;Antonio M. Risitano

  • Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria.

    Peter Hillmen;Petra Muus;Ulrich Dührsen;Antonio M. Risitano

  • Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv

    Thomas C. Thomas;Scott A. Rollins;Russell P. Rother;Michelle A. Giannoni

  • Eculizumab for congenital atypical hemolytic-uremic syndrome.

    Ralph A Gruppo;Russell P Rother

  • Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti–DC-SIGN antibody

    Paul J. Tacken;Paul J. Tacken;I. Jolanda M. de Vries;I. Jolanda M. de Vries;Karlijn Gijzen;Karlijn Gijzen;Ben Joosten;Ben Joosten

  • Mannose-Binding Lectin Is a Regulator of Inflammation That Accompanies Myocardial Ischemia and Reperfusion Injury

    Mary C. Walsh;Todd Bourcier;Kazue Takahashi;Lei Shi

  • Composition and method for treating glomerulonephritis and other inflammatory diseases

    Mark J Evans;Louis Matis;Eileen Elliott Mueller;Steven H Nye

  • Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria.

    Anita Hill;Peter Hillmen;Peter Hillmen;Stephen J. Richards;Stephen J. Richards;Dupe Elebute;Dupe Elebute

  • Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model.

    Susan K. Halstead;Femke M. P. Zitman;Peter D. Humphreys;Kay Greenshields

  • A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody.

    R P Rother;W L Fodor;J P Springhorn;C W Birks

  • Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q.

    Melanie L. Hart;Kathleen A. Ceonzo;Lisa A. Shaffer;Kazue Takahashi

  • Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria

    Peter Hillmen;Modupe Elebute;Richard Kelly;Alvaro Urbano-Ispizua

  • Eculizumab prevents intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria and unmasks low-level extravascular hemolysis occurring through C3 opsonization

    Anita Hill;Russell P Rother;Louise Arnold;Richard Kelly

  • Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria

    Anita Hill;Russell P. Rother;Xunde Wang;Sidney M. Morris

  • The management of pregnancy in paroxysmal nocturnal haemoglobinuria on long term eculizumab.

    Richard Kelly;Louise Arnold;Stephen Richards;Anita Hill

Frequent Co-Authors

Louis A. Matis
Louis A. Matis Alexion Pharma (Switzerland)
Peter Hillmen
Peter Hillmen St James's University Hospital
Neal S. Young
Neal S. Young National Institutes of Health
Gérard Socié
Gérard Socié Université Paris Cité
Monica Bessler
Monica Bessler Children's Hospital of Philadelphia
Jeff Szer
Jeff Szer Peter MacCallum Cancer Centre
Hubert Schrezenmeier
Hubert Schrezenmeier University of Ulm
Lucio Luzzatto
Lucio Luzzatto University of Florence
Ulrich Dührsen
Ulrich Dührsen University of Duisburg-Essen
Gregory L. Stahl
Gregory L. Stahl Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology or Biochemistry in the USA can open doors to a range of online degrees and health-related careers. For those seeking to advance quickly, there are options like the shortest pmhnp program for Psychiatric Mental Health Nurse Practitioners. These accelerated paths help students enter specialized healthcare roles sooner.

For individuals interested in wellness and dietary science, an accelerated nutrition degree online provides a fast-track into the field, combining scientific foundations with practical training.

Career opportunities aren’t limited to direct patient care. Management positions, such as those obtained with the cheapest online mba healthcare programs, allow biology and biochemistry graduates to step into leadership in hospitals, labs, and biotech companies.

In addition, certifications in specialized medical fields are in high demand. Comparing medical coding certification options can help students choose paths offering strong salary prospects and job security.

Exploring these online degrees and certifications can be a smart move for anyone with a background in biology or biochemistry seeking a flexible, rewarding career in healthcare.

Best Scientists Citing Russell P. Rother

Trending Scientists

Recently Published Articles